Mebiz SR Capsule (Sustained Release) 200 mg is a powerful antispasmodic agent belonging to the antimuscarinic group of drugs. It acts directly on the smooth muscle of the gut wall to relax it and reduce spasms in the intestinal tract. It is effective in relieving symptoms of irritable bowel syndrome (IBS) such as stomach pain, cramps, bloating, constipation, and diarrhea.
Mebiz SR Capsule (Sustained Release) 200 mg is indicated for the relief of abdominal pain and cramps associated with irritable bowel syndrome (IBS) and other abdominal disorders such as colitis and Crohn's disease.
| Brand Name | Mebiz SR |
|---|---|
| Type | Capsule (Sustained Release) |
| Weight | 200 mg |
| Generic | Mebeverine Hydrochloride |
| Manufacturer | Sun Pharmaceutical Ltd. |
| Available in | English বাংলা |
Mebiz SR Capsule (Sustained Release) 200 mg works by blocking the action of acetylcholine, a chemical messenger which transmits signals to the muscles in the intestine. By blocking this action, the muscles relax, resulting in relief from pain and other symptoms associated with IBS.
Mebiz SR Capsule (Sustained Release) 200 mg generally takes between 24 to 48 hours to take complete effect, depending on the individual.
Mebiz SR Capsule (Sustained Release) 200 mg is rapidly absorbed from the digestive tract, with peak levels reached within 1-3 hours.
Mebiz SR Capsule (Sustained Release) 200 mg is eliminated mainly through the feces, with only a small amount being excreted in the urine.
Mebiz SR Capsule (Sustained Release) 200 mg is available in tablets for oral administration containing 135 mg of the active ingredient. It is typically taken up to three times a day, with or without food. The maximum recommended daily dose is 405 mg.
Mebiz SR Capsule (Sustained Release) 200 mg tablets should be swallowed whole with plenty of water. They should not be crushed or chewed as this can reduce the absorption of the medication.
The most common side effects of Mebiz SR Capsule (Sustained Release) 200 mg are dry mouth, blurred vision, nausea, vomiting, abdominal pain, constipation, and headache.
Mebiz SR Capsule (Sustained Release) 200 mg is generally well tolerated and is not expected to be toxic at recommended doses.
Mebiz SR Capsule (Sustained Release) 200 mg can interact with other medications and may not be suitable for people with certain medical conditions such as renal or hepatic impairment. It should also be used with caution in people with glaucoma and those who are pregnant or breastfeeding.
Mebiz SR Capsule (Sustained Release) 200 mg can interact with other medications, particularly those which affect the nervous system such as anticholinergics, antidepressants, antihistamines, and antispasmodics. It should not be used concurrently with other anticholinergic medications.
Mebiz SR Capsule (Sustained Release) 200 mg can interact with certain medical conditions such as heart disease, glaucoma, urinary tract blockage or difficulty urinating, enlarged prostate, and narrow-angle glaucoma.
Mebiz SR Capsule (Sustained Release) 200 mg may interact with other medications and is not recommended for concurrent use with anticholinergics, antidepressants, antihistamines, and antispasmodics.
Mebiz SR Capsule (Sustained Release) 200 mg may interact with certain foods and alcohol, so it is important to check with your doctor before taking this medication if you are on a special diet or if you drink alcohol.
Mebiz SR Capsule (Sustained Release) 200 mg is not recommended for use during pregnancy, and it is not known whether it is safe to use during pregnancy. It should be avoided during the first trimester.
Mebiz SR Capsule (Sustained Release) 200 mg is not recommended for use during breastfeeding, and it is not known whether it is safe to use during breastfeeding. It should be avoided during the first trimester.
The symptoms of an acute overdose of Mebiz SR Capsule (Sustained Release) 200 mg include dry mouth, blurred vision, nausea, vomiting, abdominal cramps, constipation, and drowsiness. In severe cases, an anticholinergic crisis may occur, and medical attention should be sought immediately.
Mebiz SR Capsule (Sustained Release) 200 mg is contraindicated in patients with known hypersensitivity to the drug or any of its components. It should also be used with caution in patients with hepatic impairment or glaucoma.
Mebiz SR Capsule (Sustained Release) 200 mg should be taken as directed by your doctor, typically up to three times a day with or without food. It should be swallowed whole and should not be crushed or chewed. The maximum recommended daily dose is 405 mg.
Mebiz SR Capsule (Sustained Release) 200 mg should be stored at room temperature (15-30°C) in a well-closed container, away from moisture and sunlight.
Mebiz SR Capsule (Sustained Release) 200 mg has a volume of distribution of approximately 4 L/kg.
Mebiz SR Capsule (Sustained Release) 200 mg has a half-life of approximately 2-3 hours.
Mebiz SR Capsule (Sustained Release) 200 mg has a clearance of approximately 0.2 L/h/kg.
See in details version Mebiz SR Capsule (Sustained Release) 200 mg also Mebiz SR Capsule (Sustained Release) 200 mg in bangla
Mebiz SR Capsule (Sustained Release) 200 mg is an antispasmodic medication used to treat conditions like irritable bowel syndrome (IBS) by relaxing the muscles in the intestines and relieving spasms.
Mebeverine works by inhibiting the contraction of smooth muscles in the intestines, thus reducing cramps, spasms, and discomfort associated with gastrointestinal conditions.
Mebeverine is primarily used to treat:
Mebeverine is usually taken orally in tablet form, typically 1 tablet 3 times a day before meals. Follow your doctor's instructions for the correct dosage.
Yes, Mebeverine can be taken with or without food. However, it's generally recommended to take it before meals for best results.
Common side effects of Mebeverine may include:
Serious side effects are rare but may include:
It is recommended to consult your doctor before taking Mebeverine during pregnancy. While it is generally considered safe, it should only be used if prescribed by a healthcare provider.
Mebeverine is excreted in breast milk in small amounts. It's best to consult with your doctor before using it while breastfeeding to weigh the potential risks and benefits.
Mebeverine is generally not recommended for children under 10 years old. Always consult your healthcare provider before giving this medication to a child.
Mebeverine typically starts to relieve symptoms within a few hours of taking it. However, the full effect may take a few days of consistent use to be felt.
Mebeverine may interact with certain other medications. Inform your doctor of any other medications you are taking, including over-the-counter drugs and herbal supplements.
There is no known direct interaction between Mebeverine and alcohol. However, drinking alcohol may worsen the side effects of dizziness and drowsiness. It is advisable to limit alcohol intake.
No, Mebeverine is not addictive. It works by relaxing the smooth muscles in the intestines, and it doesn't cause dependency.
Store Mebeverine tablets in a cool, dry place, away from direct light. Keep them out of reach of children and do not use them after the expiration date on the packaging.
It is generally safe to stop taking Mebeverine without tapering off. However, consult your healthcare provider before stopping any medication.
If you miss a dose, take it as soon as you remember, unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
In case of overdose, seek immediate medical help. Symptoms of overdose may include extreme dizziness, confusion, or fainting.
Yes, Mebeverine is commonly used for treating IBS, including cases with diarrhea, as it helps reduce the frequency and severity of abdominal cramps and discomfort.
Yes, Mebeverine is effective in treating IBS with constipation by relieving cramps and spasms in the intestines, making it easier to pass stools.
While Mebeverine does not directly treat bloating, it can help alleviate the abdominal discomfort and cramping that often accompany bloating in conditions like IBS.
Mebeverine is a selective antispasmodic that targets smooth muscle in the gastrointestinal tract. Unlike some other antispasmodics, it has minimal effects on the central nervous system, leading to fewer side effects like drowsiness.
Mebeverine is not typically prescribed for stomach ulcers, but it may help alleviate some symptoms, such as abdominal discomfort, if prescribed by your doctor.
Mebeverine is specifically used for gastrointestinal conditions like IBS. It should not be used to treat general abdominal pain without a doctor's guidance.
Both Mebeverine and hyoscine are antispasmodics, but Mebeverine is more selective in its action on the gut and has fewer side effects related to the central nervous system compared to hyoscine.
Mebeverine is not typically used for nausea. It is specifically indicated for abdominal cramps and spasms, particularly in conditions like IBS.
Mebeverine helps relax the muscles in the gut, improving the movement of food through the digestive tract and relieving symptoms like cramping, bloating, and abdominal discomfort.
Yes, Mebeverine can be used long-term under the guidance of a healthcare provider, especially for managing chronic conditions like IBS. Regular check-ups are recommended to monitor its effectiveness and side effects.
Some Mebeverine tablets may contain lactose. If you are lactose intolerant, speak with your healthcare provider to find a suitable alternative.
There is no known interaction between Mebeverine and caffeine. However, excessive caffeine consumption may exacerbate symptoms like abdominal discomfort or diarrhea in some individuals.
Weight gain is not a common side effect of Mebeverine. However, changes in appetite or digestion related to IBS might affect weight, and these issues may improve with Mebeverine treatment.
Mebeverine does not typically affect blood pressure. However, if you have a history of blood pressure issues, discuss this with your healthcare provider before starting the medication.
Yes, Mebeverine is effective for managing chronic digestive conditions such as IBS. Your doctor will help tailor the treatment to suit your needs.
There are no known significant long-term effects of Mebeverine use when taken as prescribed. However, it's important to have regular follow-up with your healthcare provider to monitor any side effects.
Yes, Mebeverine can generally be used alongside probiotics. However, it's best to consult your healthcare provider to ensure the combination is appropriate for your condition.
In many countries, Mebeverine is available only by prescription. It is not typically sold over-the-counter for self-medication.
Mebeverine generally does not cause drowsiness or impair motor skills, but if you experience dizziness or other side effects, avoid driving and consult your healthcare provider.
Mebeverine is unlikely to cause constipation; in fact, it is used to help alleviate constipation-related symptoms in IBS. However, some individuals may experience digestive upset.
Although Mebeverine is not specifically indicated for menstrual cramps, it may help relieve abdominal discomfort if cramps are related to gastrointestinal spasms.
Mebeverine does not directly affect blood sugar levels, but if you have diabetes, always consult your healthcare provider before starting any new medication.
Mebeverine is generally considered safe for people with liver conditions. However, if you have liver disease, your doctor may monitor your liver function while using Mebeverine.
Some individuals may experience dizziness or lightheadedness when taking Mebeverine. If this occurs, avoid driving or operating heavy machinery until the symptoms resolve.
Yes, generic versions of Mebeverine are available in many countries, typically under the name "Mebeverine" or similar variations.
If you experience symptoms of an allergic reaction (rash, swelling, difficulty breathing), stop taking Mebeverine immediately and seek medical attention.
While Mebeverine is not specifically used for gas pain, it can help reduce abdominal discomfort and bloating that may accompany gas in some individuals.
Mebeverine may help reduce the frequency and severity of diarrhea associated with IBS by relaxing the intestinal muscles and reducing spasms.
Mebeverine helps with constipation-related discomfort by relaxing the muscles in the intestines and allowing for smoother bowel movements.
The usual dosage for Mebeverine is 135 mg, 3 times a day. However, always follow the specific dosing instructions given by your healthcare provider.
Mebeverine is not specifically indicated for Crohn's disease, but it may help alleviate gastrointestinal spasms and discomfort associated with the condition.